SCHEMBL7822997

SCHEMBL7822997

CNc1nc(OCc2ccccc2)ccc1N

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 1/20 0.56
GAA P10253 3/20 0.43
PKM P14618 1/20 0.42
GRM5 P41594 2/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
TLR8 Q9NR97 1/20 0.40
TLR7 Q9NYK1 1/20 0.40
HRH4 Q9H3N8 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
TSHR P16473 1/20 0.40
MAPT P10636 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TRPV3 Q8NET8 1/20 0.40
LTA4H P09960 1/20 0.40
MAPK14 Q16539 1/20 0.40
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2194417 0.84 EGFR (0.45) NUDT1GAAPKMGRM5LMNA
SCHEMBL5301894 0.81 GRM5 (0.44) NUDT1GRM5LMNATLR8TLR7
SCHEMBL2193858 0.81 SMN1; SMN2 (0.44) NUDT1GAALMNAMAPTRAB9A
SCHEMBL2195003 0.80 EGFR (0.43) NUDT1GAALMNAHTTTLR8
SCHEMBL23274021 0.80 NUDT1 (0.49) NUDT1GAAPKMHTTHRH4
SCHEMBL2191517 0.79 LTA4H (0.49) NUDT1GAAPKMGRM5HRH4
SCHEMBL7833949 0.79 ALDH1A1 (0.38) NUDT1LMNAHTTL3MBTL1TSHR
SCHEMBL29424833 0.79 LTA4H (0.49) NUDT1GAAPKMGRM5HRH4
SCHEMBL2197014 0.78 EGFR (0.43) NUDT1GAAHTTL3MBTL1MAPT
SCHEMBL2196709 0.78 NPC1 (0.41) NUDT1GAALMNAHTTTLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
CN-1060173-C Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 2001-01-03 CN disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
CN-1118781-A Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 1996-03-20 CN disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed